Iterum Therapeutics (ITRM)
(Real Time Quote from BATS)
$0.76 USD
+0.03 (3.83%)
Updated Aug 4, 2025 11:56 AM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Iterum Therapeutics PLC has a market cap of $30.84M, which represents its share price of $0.73 multiplied by its outstanding shares number of 42.13M. As a small-cap company, ITRM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ITRM 0.76 +0.03(3.83%)
Will ITRM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ITRM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ITRM
ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down
ITRM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ITRM
Iterum Therapeutics Q2 Earnings Preview
Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025 | ITRM ...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ITRM Stock News